Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare NASDAQ:APHA NASDAQ:CRON NASDAQ:TLRY NYSE:USNA On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeAPHAAphria$15.38$15.48$2.78▼$32.29$4.87B2.6721.83 million shsN/ACRONCronos Group$2.52+1.6%$2.57$1.60▼$3.16$964.88M1.122.01 million shs1.20 million shsTLRYTilray Brands$1.49+0.7%$1.37$0.35▼$2.32$1.67B1.9850.01 million shs48.14 million shsUSNAUSANA Health Sciences$20.88+1.2%$28.06$18.69▼$41.83$381.39M0.61176,104 shs230,414 shsTen Starter Stocks For Beginners to Buy NowJust getting into the stock market? These 10 simple stocks can help beginning investors build long-term wealth without knowing options, technicals, or other advanced strategies.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceAPHAAphria0.00%0.00%0.00%0.00%0.00%CRONCronos Group+2.90%0.00%-6.06%+20.98%+11.21%TLRYTilray Brands+2.07%-3.90%+19.35%+114.96%-11.90%USNAUSANA Health Sciences-0.76%-1.96%-28.71%-35.38%-43.53%Compare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeAPHAAphria$15.38$15.48$2.78▼$32.29$4.87B2.6721.83 million shsN/ACRONCronos Group$2.52+1.6%$2.57$1.60▼$3.16$964.88M1.122.01 million shs1.20 million shsTLRYTilray Brands$1.49+0.7%$1.37$0.35▼$2.32$1.67B1.9850.01 million shs48.14 million shsUSNAUSANA Health Sciences$20.88+1.2%$28.06$18.69▼$41.83$381.39M0.61176,104 shs230,414 shsTen Starter Stocks For Beginners to Buy NowJust getting into the stock market? These 10 simple stocks can help beginning investors build long-term wealth without knowing options, technicals, or other advanced strategies.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceAPHAAphria0.00%0.00%0.00%0.00%0.00%CRONCronos Group+2.90%0.00%-6.06%+20.98%+11.21%TLRYTilray Brands+2.07%-3.90%+19.35%+114.96%-11.90%USNAUSANA Health Sciences-0.76%-1.96%-28.71%-35.38%-43.53%Compare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceAPHAAphria 0.00N/AN/AN/ACRONCronos Group 1.00SellN/AN/ATLRYTilray Brands 2.00Hold$2.0034.23% UpsideUSNAUSANA Health Sciences 1.50Reduce$36.0072.46% UpsideCurrent Analyst Ratings BreakdownLatest CRON, APHA, TLRY, and USNA Analyst RatingsDateCompanyBrokerageActionRatingPrice TargetDetails10/24/2025CRONCronos GroupWeiss RatingsSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingReiterated RatingSell (D+)10/24/2025TLRYTilray BrandsWeiss RatingsSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingReiterated RatingSell (D-)10/24/2025USNAUSANA Health SciencesWeiss RatingsSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingReiterated RatingSell (D+)10/21/2025USNAUSANA Health SciencesZacks ResearchSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingDowngradeHold ➝ Strong Sell10/9/2025TLRYTilray BrandsAtb Cap MarketsSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingDowngradeHold ➝ Strong Sell10/8/2025CRONCronos GroupWeiss RatingsSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingReiterated RatingSell (D+)10/8/2025TLRYTilray BrandsWeiss RatingsSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingReiterated RatingSell (D-)10/8/2025USNAUSANA Health SciencesWeiss RatingsSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingReiterated RatingSell (D+)9/27/2025CRONCronos GroupWeiss RatingsSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingReiterated RatingSell (D+)9/27/2025TLRYTilray BrandsWeiss RatingsSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingReiterated RatingSell (D-)9/27/2025USNAUSANA Health SciencesWeiss RatingsSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingReiterated RatingSell (D+)(Data available from 10/24/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)Compare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookAPHAAphria$405.96M12.00$0.09 per share166.43$4.80 per share3.20CRONCronos Group$117.61M8.20$0.00 per share5,179.23$2.90 per share0.87TLRYTilray Brands$821.31M2.04$0.15 per share10.03$1.35 per share1.10USNAUSANA Health Sciences$854.50M0.45$3.77 per share5.54$27.92 per share0.75Compare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateAPHAAphria-$63.21M-$0.06N/A219.71N/A-36.10%-2.30%-1.66%N/ACRONCronos Group$41.08M$0.0550.4084.00N/A14.19%-3.78%-3.62%11/11/2025 (Estimated)TLRYTilray Brands-$2.19B-$2.27N/AN/AN/A-258.54%-6.79%-5.30%1/9/2026 (Estimated)USNAUSANA Health Sciences$42.03M$1.8023.727.221.021.86%6.96%4.97%N/ALatest CRON, APHA, TLRY, and USNA EarningsDateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails10/21/2025Q3 2025USNAUSANA Health Sciences$0.47-$0.15-$0.62-$0.36$224.97 million$214.00 million10/9/2025Q1 2026TLRYTilray Brands-$0.03-$0.0002+$0.0298N/A$205.75 million$209.50 million10/9/2025Q3 2025USNAUSANA Health SciencesN/A$0.56N/AN/AN/A$200.22 million8/7/2025Q2 2025CRONCronos Group-$0.02-$0.10-$0.08-$0.10$45.73 million$33.46 million7/28/2025Q4 2025TLRYTilray Brands-$0.03$0.02+$0.05-$1.30$250.41 million$224.54 millionCompare DividendsCompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive GrowthAPHAAphriaN/AN/AN/AN/AN/ACRONCronos GroupN/AN/AN/AN/AN/ATLRYTilray BrandsN/AN/AN/AN/AN/AUSNAUSANA Health SciencesN/AN/AN/AN/AN/ACompare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioAPHAAphria0.252.361.17CRONCronos GroupN/A24.6523.53TLRYTilray Brands0.152.621.56USNAUSANA Health SciencesN/A2.151.47Compare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipAPHAAphria10.30%CRONCronos Group8.71%TLRYTilray Brands9.35%USNAUSANA Health Sciences54.25%Insider OwnershipCompanyInsider OwnershipAPHAAphriaN/ACRONCronos Group7.30%TLRYTilray Brands0.84%USNAUSANA Health Sciences0.63%Compare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableAPHAAphria1,200316.80 millionN/AOptionableCRONCronos Group450382.89 million354.94 millionOptionableTLRYTilray Brands2,8421.12 billion1.11 billionOptionableUSNAUSANA Health Sciences1,70018.27 million18.16 millionOptionableCRON, APHA, TLRY, and USNA HeadlinesRecent News About These CompaniesUsana signals in-house Hiya manufacturing and cost reduction initiatives while expanding DTC strategyOctober 23 at 7:13 PM | msn.comUsana signals in-house Hiya manufacturing and cost reduction initiatives while expanding DTC strategyOctober 23 at 7:13 PM | msn.comUSANA (USNA) Stock Trades Down, Here Is WhyOctober 23 at 7:13 PM | msn.comUsana Health Sciences Inc (USNA) Q3 2025 Earnings Call Highlights: Strategic Moves and Sales ...October 23 at 7:13 PM | finance.yahoo.comUSANA Health Sciences (NYSE:USNA) Releases FY 2025 Earnings GuidanceOctober 23 at 7:05 PM | marketbeat.comUSANA Health Sciences (NYSE:USNA) Releases Earnings Results, Misses Expectations By $0.62 EPSOctober 23 at 5:06 PM | marketbeat.comUSANA Health Sciences (NYSE:USNA) Stock Rating Lowered by Zacks ResearchOctober 23 at 7:13 AM | marketbeat.comUsana Health Sciences Inc (USNA) Q3 2025 Earnings Report Preview: What To Look ForOctober 22 at 10:50 PM | finance.yahoo.comUSANA Health Sciences (USNA) Reports Q3 Loss, Misses Revenue EstimatesOctober 22 at 6:16 PM | zacks.comUSANA Health: Q3 Earnings SnapshotOctober 22 at 5:48 PM | timesunion.comTUSANA (NYSE:USNA) Reports Q3 In Line With Expectations But Stock Drops 10.2%October 22 at 5:48 PM | finance.yahoo.comUSANA Health Reports Q3 2025 Sales IncreaseOctober 22 at 4:51 PM | tipranks.comUSANA Health Sciences Reports Third Quarter 2025 Results and Updates Full-Year OutlookOctober 22 at 4:05 PM | businesswire.comEarnings To Watch: Usana Health Sciences Inc (USNA) Reports Q3 2025 ResultOctober 21 at 12:45 AM | finance.yahoo.comUsana Health Sciences Inc (USNA) Q3 2025 Earnings Report Preview: What To ExpectOctober 21 at 9:25 AM | finance.yahoo.comUSANA Updates the Timing of the Release of Third Quarter 2025 Earnings Release and Conference CallOctober 20, 2025 | businesswire.comUSANA Health Sciences (USNA) Expected to Announce Quarterly Earnings on TuesdayOctober 20, 2025 | americanbankingnews.comUSANA (USNA) Reports Q3: Everything You Need To Know Ahead Of EarningsOctober 20, 2025 | msn.comUSANA's Vitamin D Supplement Shines Bright with ConsumerLab.com Seal of Approval--Setting the Standard for Product QualityOctober 16, 2025 | prnewswire.comUSANA Health Sciences (USNA) Projected to Post Quarterly Earnings on TuesdayOctober 14, 2025 | marketbeat.comUSANA Health Sciences (USNA) Is Down 25.4% After Weak Q3 Outlook and Compensation Plan Impact—What’s ChangedOctober 13, 2025 | uk.finance.yahoo.comNew MarketBeat Followers Over TimeMedia Sentiment Over Time Top HeadlinesView All HeadlinesSoundHound Breaks Critical Resistance: How High Can It Get Now?By Thomas Hughes | September 28, 2025October’s Top 5 Stocks Poised for Big BreakoutsBy Thomas Hughes | October 1, 2025Micron’s Stock Price Rally Is Not Over: MU $190 Is Coming SoonBy Thomas Hughes | September 25, 2025Is Tilray's Stock Price Surge a Pipe Dream of Political Hype?By Jeffrey Neal Johnson | October 1, 2025Why Micron Stock Could Soar 35% on AI Memory DemandBy Thomas Hughes | October 21, 2025CRON, APHA, TLRY, and USNA Company DescriptionsAphria NASDAQ:APHAAphria Inc. cultivates, processes, produces, markets, distributes, and sells medical cannabis in Canada and internationally. The company offers pharmaceutical-grade medical cannabis, adult-use cannabis, and cannabis-derived extracts and derivative cannabis products under the Solei, RIFF, Good Supply, Aphria, P'tite Pof, and Broken Coast brands. It serves patients and consumers through distributors and online. The company is headquartered in Leamington, Canada.Cronos Group NASDAQ:CRON$2.52 +0.04 (+1.61%) Closing price 04:00 PM EasternExtended Trading$2.53 +0.01 (+0.40%) As of 04:37 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Cronos Group Inc. operates as a cannabinoid company that engages in the cultivation, production and marketing of cannabis products in Canada, Israel, and Germany. It offers dried flower, pre-rolls, oils, vaporizers, edibles, and cannabis tinctures under the Spinach, Lord Jones, and PEACE NATURALS brands. Cronos Group Inc. was founded in 2012 and is based in Toronto, Canada.Tilray Brands NASDAQ:TLRY$1.49 +0.01 (+0.68%) Closing price 04:00 PM EasternExtended Trading$1.48 0.00 (-0.34%) As of 04:47 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Tilray, Inc. engages in the research, cultivation, processing, and distribution of medical cannabis. The company offers its products in Argentina, Australia, Canada, Chile, Croatia, Cyprus, the Czech Republic, Germany, New Zealand, and South Africa. Tilray, Inc. is headquartered in Canada.USANA Health Sciences NYSE:USNA$20.88 +0.25 (+1.19%) Closing price 03:59 PM EasternExtended Trading$20.65 -0.23 (-1.08%) As of 04:10 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.USANA Health Sciences, Inc. develops, manufactures, and sells science-based nutritional, personal care, and skincare products in the Asia Pacific, the Americas, and Europe. The company offers USANA nutritional products that comprise essentials/CellSentials, such as vitamin and mineral supplements that provide a foundation of total body nutrition for various age groups; optimizers consisting of targeted supplements that are designed to meet cardiovascular, skeletal/structural, and digestive health needs; and food that include meal replacement shakes, snack bars, and other related products. It also provides Celavive, a skin care regimen for various skin care types and ethnicities; and other products for prenatal, infant, and young child age groups. In addition, the company offers materials and online tools to assist associates in building their businesses, as well as in marketing products. It offers its products through retail stores and online. The company has a research collaboration agreement with Beijing University of Chinese Medicine; and National Sports Training Bureau. USANA Health Sciences, Inc. was founded in 1992 and is headquartered in Salt Lake City, Utah. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30DroneEcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerFlying CarGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMade In AmericaMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSilverSocial MediaSolarSpaceTechnologyTelecomToyUraniumUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas Freeport-McMoRan Posts Strong Earnings Despite Indonesia Shutdown Tesla’s Earnings Review: Does the Juice Justify the Squeeze? Warner Bros. Bidding War Potential: How High Could WBD Shares Go? Logitech Eyes Breakout Before Earnings—Citigroup Sees 30% Upside Boeing Takes Off as FAA Greenlights 737 MAX Production Boost Capital One Just Flashed a Buy Signal—New Highs Could Be Next Why Intuitive Surgical Is a No-Brainer for Long-Term Investors Is Oracle’s AI Rally Over? Wall Street Thinks ORCL Could Hit $400 Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
